Marta Benavent-Viñuales

6PUBLICATIONS
47CO-AUTHORS
Haematological tumoursSolid tumoursPredictive and prognostic markersMolecular targetsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.

|Jun 09, 2026
Secretory carcinoma of the breast: a report of six cases with different immunophenotypes and molecular subtypes.

|Mar 06, 2026
UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer.

Ana Gil-Torralvo, M Ángeles Domínguez-Cejudo, Sonia Molina-Pinelo

|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca

|Sep 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo

|Jan 31, 2021
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).

Marta Benavent, Javier Sastre, Ignacio García Escobar

Pageof 1

Frequent Collaborators

3 joint publications

Paula Jimenez-Fonseca

2 joint publications

Rocio Garcia-Carbonero

2 joint publications

Teresa Alonso-Gordoa

2 joint publications

Alex Teulé